MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Validation of smartphone-based active tests with structural neuroimaging in Huntington’s disease

    J. Rennig, S. Holiga, D. Hawellek, F. Lipsmeier, J. Dorn, S. Schobel, C. Simillion, M. Lindemann (Basel, Switzerland)

    Objective: Explore the association of smartphone-based active tests in the Roche Huntington’s disease (HD) Digital Monitoring Platform (dMP) with brain imaging. Background: Remote digital monitoring…
  • MDS Virtual Congress 2021

    Intergenerational repeat instability of TTTCA expansions in SAMD12 might be the major cause of the genetic anticipation in familial cortical myoclonic tremor with epilepsy

    ZD. Cen, XH. Chen, HT. Wang, DH. Yang, F. Zhang, Y. Chen, S. Chen, LB. Wang, P. Liu, F. Xie, B. Wang (Hangzhou, China)

    Objective: To delineate and analyze the relationship between genetic and clinical features in 78 patients from 23 familial cortical myoclonic tremor with epilepsy type 1 (FCMTE1) pedigrees. Background:…
  • MDS Virtual Congress 2021

    Cerebellar bioenergetic depletion following ubiquinol supplementation in a patient with COQ8A-related ataxia

    J. Prasuhn, M. Göttlich, B. Ebeling, C. Bodemann, S. Großer, I. Wellach, K. Reuther, H. Hanssen, N. Brüggemann (Lübeck, Germany)

    Objective: To non-invasively map the individual treatment response in a patient with COQ8A-related ataxia following coenzyme Q10 supplementation. Background: Primary coenzyme Q10 (CoQ10) deficiency is…
  • MDS Virtual Congress 2021

    Electrophysiological testing aids the diagnosis of tremor versus myoclonus in clinically challenging patients

    C. Everlo, JW. Elting, M. Tijssen, M. V.D. Stouwe (Groningen, Netherlands)

    Objective: We investigated how clinical electrophysiological testing can help to distinguish tremor versus myoclonus. Background: Tremor is the most common movement disorder and myoclonus its…
  • MDS Virtual Congress 2021

    Facial Paralysis Associated with COVID-19: a systematic review.

    B. Franco, G. Aragão, M. Pereira, I. Vasconcelos, A. Nunes, C. Filho (Salvador, Brazil)

    Objective: To develop an overview of facial paralysis associated with COVID-19 to identify the clinical pattern, other symptoms, disease severity, besides discussing epidemiologic characteristics. Background:…
  • MDS Virtual Congress 2021

    PERCEPTION OF INDIVIDUALS WITH PARKINSON´S DISEASE ABOUT ISOLATION DURING THE COVID-19 PANDEMIC

    R. Pasquarelli Volpe, L. Laskovski, S. Mahmoud Smaili (Londrina, Brazil)

    Objective: To explore the knowledge of individuals with PD about COVID-19's world pandemic, and to investigate their perception about its impacts and consequences. Background: The…
  • MDS Virtual Congress 2021

    Patterns of Improvement with Valbenazine in Patients with Tardive Dyskinesia

    C. Correll, T. Carmack, C. Shah, L. Lundt (Glen Oaks, USA)

    Objective: To characterize different patterns of improvement with valbenazine (VBZ) in patients with tardive dyskinesia (TD) using Abnormal Involuntary Movement Scale (AIMS) data from KINECT…
  • MDS Virtual Congress 2021

    Telephone Visit Efficacy for Parkinson’s Disease During the COVID-19 Pandemic

    F. Abu Ahmad, R. Postuma (Montreal, Canada)

    Objective: To compare telephone and in-person visits in the clinical care of Parkinson’s disease (PD) patients. Background: There has been growing interest in using telemedicine…
  • MDS Virtual Congress 2021

    Home Health Management of Parkinson’s Disease Deep Brain Stimulation: A Randomized Clinical Trial

    G. Duffley, A. Wright, C. Hess, A. Ramirez-Zamora, P. Zeilman, S. Chiu, A. Szabo, B. Lutz, K. Foote, M. Okun, C. Butson (Salt Lake City, USA)

    Objective: Evaluate the efficacy of home health DBS postoperative management in an effort to reduce travel burden and improve access. Background: The travel required to…
  • MDS Virtual Congress 2021

    Should Amantadine DR/ER Be Considered Prior to Device-Aided Therapies for Parkinson’s Disease?

    R. Hauser, S. Goud, A. Formella (Tampa, USA)

    Objective: Evaluate delayed release/extended release amantadine (AMT DR/ER) capsules for motor complications in patients meeting 5-2-1 criteria for device-aided therapies (DAT) in advanced Parkinson disease.…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley